This 2021 ASBrS exhibitor learning session was moderated by ICE3 investigator Dr. Richard E. Fine who discussed the ICE3 Clinical Trial on Cryoablation in Small, Low-Risk Breast Cancer Interim Results and provided case studies by fellow ICE3 Investigators Dr. Susan A. Seedman and Dr. Michael Berry.
CONTACT US
Headquarters
IceCure Medical Ltd 7 Ha’Eshel St., PO Box 316, 3088900 Caesarea Israel. T +972-4-623-0333 F +972-4-623-0222 E info@icecure-medical.com